Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

16.04

+0.50 (3.22%)

At close: Feb 13, 2026, 4:00 PM EST

16.15

+0.11 (0.69%)

After-hours: Feb 13, 2026, 7:09 PM EST

Adaptive Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,467	2,479	885	709	1,093	3,960
Market Cap Growth	112.64%	180.23%	24.72%	-35.07%	-72.41%	-51.03%
Enterprise Value	2,437	2,476	842	569	798	3,441
Last Close Price	16.04	16.24	6.00	4.90	7.64	28.06
PS Ratio	8.79	8.95	4.94	4.17	5.90	25.66
PB Ratio	11.27	11.02	4.37	2.30	2.35	6.56
P/TBV Ratio	25.15	25.27	11.02	3.85	3.23	8.31
EV/Sales Ratio	8.80	8.94	4.70	3.34	4.31	22.29
Debt / Equity Ratio	0.94	0.94	1.10	0.74	0.50	0.19
Net Debt / Equity Ratio	-0.13	-0.13	-0.16	-0.38	-0.57	-0.76
Net Debt / EBITDA Ratio	0.77	0.77	0.25	0.65	1.48	2.35
Net Debt / FCF Ratio	-	-	0.34	0.70	1.32	1.80
Asset Turnover	0.53	0.53	0.30	0.22	0.21	0.15
Inventory Turnover	18.09	18.09	15.30	13.68	11.84	11.50
Quick Ratio	3.09	3.09	2.71	4.38	4.91	3.27
Current Ratio	3.34	3.34	2.89	4.66	5.12	3.54
Return on Equity (ROE)	-27.82%	-27.82%	-62.49%	-58.34%	-37.52%	-30.77%
Return on Assets (ROA)	-6.79%	-6.79%	-16.18%	-16.60%	-14.06%	-12.81%
Return on Capital Employed (ROCE)	-13.50%	-13.50%	-35.20%	-35.20%	-26.80%	-25.80%
Earnings Yield	-2.41%	-2.40%	-18.03%	-31.75%	-18.32%	-5.23%
FCF Yield	-	-	-11.18%	-23.54%	-18.33%	-6.43%
Buyback Yield / Dilution	-3.14%	-3.14%	-1.88%	-1.31%	-1.54%	-6.96%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q